We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly VP Says PTO Reform Plan Could Weaken Drug Patent Defenses
Lilly VP Says PTO Reform Plan Could Weaken Drug Patent Defenses
April 29, 2005
Drugmakers could have a harder time defending patents under a U.S. Patent and Trademark Office (PTO) reform proposal that would allow third parties to challenge the validity of new patents before PTO administrative judges rather than in the courts, according to an Eli Lilly executive.